AMAP Greenland and the Faroe Islands 1997-2001
Bio-Physical Indicators
Epidemiological
Effect Markers
Molecular/Genetic
Effect Markers
Health Statistic
E
R
Morbidity/Mortality data
Cancer incidence
Genetic susceptibility
Studies
R
R Gene polymorfisms
Gene ekspression (mRNA)
Fertility studies:
R
R
Receptor/hormone toxicology;
Measurements in steroid hormone
cleared blood: Estrogenic -,
Androgenic- like activities
Time to pregnancy (TTP)
R
Time or number of menstrual
cycles it takes a couple to conceive
from discontinuation of
contraception
Dioxin-like activities in serum
in vitro hormone receptor bindings
Semen quality and quantity
R
Sperm count/volume
Sperm quality/mobility
Sex hormones
(In blood from male partners
providing semen samples and
their spouses)
R
R
FSH, Inhibin-B, LH,
Testosterone, Estradiol
Sex hormone binding globulin
Osteocalcin, pyridolins
Pregnancy outcome
Developmental anomalies
Developmental effects
E
R
R
Abortion (spontanous)
Gestational age
Birth weight/length
Placenta weight
Sex (single/multiple)
Maldescent testis
Hypospadias
Epispadias
Ano-genital distance
and other indicies
Breast milk (POPs, Fattyacids)
R
Estrogenic-, Androgenic- and
Dioxin-like activities
Cytochrome P450 modulations, DNA
adducts
Immunological effects
R
Hospitalization
Vaccination response
R
R
Antibody (HIB), Vitamin A and
Cytokines, Complement system
Dioxin-like activities
Neurological effects
R
R
Milestones + age
Preschool tests:
Neurophysiological
Neuropsychological
Audiogram and Visual tests
R
R
Thyroid hormone
Estrogenic- and
Dioxin-like activities
GSHRd, GSHPx, Ubiquinol
10/Ubiquinone 10, Ox-LDL, F2-
Isoprostanes
R = recommended
E = essential
|